- $1.48bn
- $2.27bn
- $1.37bn
Brief: CONMED Announces Chief Financial Officer Transition
Brief: Conmed Corp - Announces Exit From Gastroenterology Product Lines
U.S. RESEARCH ROUNDUP-Acadia Pharmaceuticals, Applovin Corp, Centuri Holdings
Surgical devices maker Conmed's Q3 sales rise 6.7%, slightly beating estimates
Brief: Conmed Q3 Adjusted EPS USD 1.08 Vs. IBES Estimate USD 1.05
Conmed Corp reports results for the quarter ended June 30 - Earnings Summary
Brief: Conmed Q2 Adjusted EPS USD 1.15 Vs. IBES Estimate USD 1.12
Brief: Conmed enters into eighth ammended credit agreement - SEC filing
U.S. STOCKS ON THE MOVE-Moderna, Cardinal Health, Adobe
U.S. STOCKS ON THE MOVE-CureVac, Conagra, Oklo
Conmed slips after Needham downgrade
U.S. STOCKS ON THE MOVE-Esty, America's Car-Mart, ImmunoPrecise
Conmed slips after Needham downgrade
Brief: Conmed Corporation Appoints Laverne Council As Chair Of The Board Of Directors
U.S. RESEARCH ROUNDUP-Avepoint, Meta, United Therapeutics
Conmed Corp reports results for the quarter ended March 31 - Earnings Summary
U.S. RESEARCH ROUNDUP-Conmed, McKesson, Veralto
Conmed Corp reports results for the quarter ended December 31 - Earnings Summary
Brief: Conmed Q4 Adjusted EPS USD 1.34 Vs. IBES Estimate USD 1.2